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SS18.
Ruptured Abdominal Aortic Aneurysm: The Harborview Experience-
Part 2
Benjamin W Starnes, Elina Quiroga, Nam T. Tran, Thomas Hatsukami,
Mark Meissner, Ted Kohler, Michael Sobel. University of Washington,
Seattle, WA
Objectives: Our institution treats between 30 and 50 patients per year
with ruptured abdominal aortic aneurysm (rAAA) and our overall 30-day
mortality between 2002 and 2007 averaged 60%. We sought to evaluate the
effect on mortality of the implementation of an algorithm to manage these
patients with a preference for endovascular aneurysm repair (EVAR) when
feasible.
Methods: Patients presenting with rAAA between July 1, 2002 and
June 30, 2007 served as retrospective controls. The treatment group con-
sisted of patients presenting after July 1, 2007, who were treated with a
structured protocol including early proximal control with an aortic occlusion
balloon, permissive hypotension, and endovascular repair when possible.
The primary outcome measure was 30-day mortality. Data were analyzed
using Chi Square and Fisher’s Exact Test where appropriate.
Results: The 30-day mortality for the 131 control patients was 60%.
After implementation of the protocol, 50 patients with rAAAweremanaged.
Eighteen (36%) underwent successful EVAR, and twenty-eight (46%) un-
derwent open repair. Four patients (8%) received comfort care only. Three
patients in the EVAR group (17%) and thirteen patients in the open group
(46%) died during the follow up period for an overall 30-day mortality rate
of 35% (p0.006 vs 60% of controls). There was no difference in the
incidence of hypotension on presentation (SBP80mmHg) between con-
trol (65%) and treatment (61%) groups. In the treatment group, 28/46
(61%) presented with hypotension. The incidence of hypotension between
open and EVAR patients did not differ in the treatment group. Average
transfusion requirement for those undergoing EVAR was 1 unit (0-13) and
for open repair, 8 units (0-19). The difference in transfusion requirement
amongst survivors in each group was not different (p 0.06).
Conclusions: An algorithm using early proximal aortic control with a
balloon catheter, permissive hypotension, and endovascular repair when
possible reduced rAAA mortality by 40% (absolute risk reduction of 25%).
Using this approach in a large, urban hospital, the majority of patients
presenting with rAAA survived. Further reduction in mortality is expected as
improvement in endovascular techniques allows treatment of more patients
with complex aortic anatomy.
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SS19.
Implications of Endoleaks on Aneurysm Sac Pressures Following En-
dovascular Repair of Elective and Ruptured Aortic Aneurysms
Manish Mehta, John B Taggert, Sean P Roddy, Yaron Sternbach, Paul B
Kreienberg, Ashik Desai, Philip S K Paty, Kathleen J Ozsvath, Benjamin B
Chang, Dhiraj M Shah, R Clement Darling, III. Albany Medical College,
Albany, NYPurpose: To analyze the implications of endoleaks on sac pressures
following endovascular aneurysm repair (EVAR) of elective and ruptured
abdominal aortic aneurysms (AAA).
Methods: Since 2006, 480 patients underwent EVAR and simulta-
neous placement of the cardioMEMS Endosure® wireless pressure sensor in
the excluded aneurysm sac for elective (n455, 94%) and ruptured (n25,
6%) AAA. Aneuryms sac pressures were measured prior and subsequent to
completion of stentgraft placement, at 1 month, and every 6 months
thereafter. Patients were also followed-up by CTA at 6-12 month intervals,
and evaluated for the presence of endoleaks. All patients with type I
endoleaks were treated at the time of diagnosis, patients with type II
endoleaks at 6 months without decrease in aneurysm size were treated by
coil embolization. The ratio of sac to systemic pressure was used to create a
standardized pressure index for systolic pressures (SPI), diastolic pressures
(DPI), mean (MPI), and pulse pressures (PPI).
Results: At postoperative time intervals ranging from 1 day to 24
months, in patients with No Endoleak (n364, 76%), there were no
significant differences in any of the mean pressure indexes, and all indexes
decreased at 2 wks; SPI (0.09), DPI (0.2), MPI (0.12), and PPI (0.03). In
patients with Type II Endoleak (n102, 21%), there were marked elevations
in all mean pressure indexes when compared to No Endoleak group. In this
group, all indexes were higher than in patients without endoleak up to 6
months; SPI (0.30), DPI (0.46), MPI (0.38), and PPI (0.2). Treatment of
Type II endoleaks lead to a significant reduction in these indexes; SPI (0.08),
DPI (0.18),MPI (0.12), and PPI (0.02). Patients with Type I endoleaks had
consistent elevation in all pressure indexes that approximated pre-exclusion
aneurysm sac pressures; SPI (0.8), DPI (1.20), MPI (0.92), and PPI (0.42)
and these indexes decreased significantly following treatment of the type I
endoleaks. There was no difference in sac pressures in any group when
comparing EVAR for elective vs. ruptured AAA.
Conclusions: Presence of Type I and II endoleaks can be predicted on
by evaluating aneurysm sac pressures; the DPI and MPI are significantly
elevated in presence of Type I and II endoleaks. Successful treatment of
endoleaks can be predicted by decrease in aneurysm sac pressures.
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SS20.
Asymptomatic Perioperative Myocardial Damage is Associated with
Poor Long-term Outcome after Vascular Surgery
Olaf Schouten1, Tamara A Winkel1, Gijs MJM Welten1, Hero van Urk1,
Hence JMVerhagen1, Jeroen J. Bax2, Don Poldermans1. 1ErasmusMedical
Center Rotterdam, Rotterdam, Netherlands; 2Leiden University Medical
Center, Leiden, Netherlands
Background: Cardiac troponin T (cTnT) release is a sensitive marker
for myocardial injury and occurs frequently after vascular surgery. However,
the prognosis of cTnT elevations without clinical symptoms and/or new
electrocardiographic changes (asymptomatic cTnT release) is unknown.
Aim: To assess the long-term prognosis of vascular surgery patients
who experience perioperative asymptomatic myocardial damage.
Methods:A total of 1545 patients undergoing elective vascular surgery
were enrolled. Baseline characteristics and medication were noted. Routine
sampling of cTnT and ECG recording was performed on day 1, 3, and 7 after
surgery and at the day of discharge. Elevated cTnT was defined as serum
concentrations  0.01 ng/ml. The mean follow-up was 3.7 years and
mortality was noted.
Results:A total of 213 (14%) patients experienced asymptomatic cTnT
release, median 0.08 ng/ml (IQR 0.04-0.20 ng/ml), while 71 (5%) patients
had symptomatic cTnT release. During follow-up 304 patients (20%) died.
Mortality was higher in patients with asymptomatic cTnT release compared
to patients without cTnT release (13% vs. 40%; p0.001, figure). After
adjustment for risk factors and type and site of surgery, the association
between asymptomatic elevated cTnT levels and increased late mortality
persisted (adjusted HR 2.3; 95% CI 1.8-3.0) and risk increased with higher
cTnT levels (HR 1.64 for every 0.10 ng/ml increase, p0.02). Elevated
cTnT had prognostic value irrespective of baseline creatinine value or renal
dysfunction after surgery.
Conclusions: Asymptomatic cTnT release, without clinical symptoms
or new ECG changes, is associated with an increased long-term mortality in
patients undergoing vascular surgery.
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SS21.
Future of Vascular Surgery is in the Office
Krishna Jain, John S Munn, Mark C Rummel, Sarat K Vaddineni, Chris D
Longton. Advanced Vascular Surgery, kalamazoo, MI
Objective: The Practice of Vascular Surgery is under pressure from
various specialties and payers. Our group started office based procedures in
May of 2007. The purpose of this paper is to study the impact of this change
on our case volume, office revenue and the financial impact on healthcare
system.
Methods: Between 5/1/06 and 4/30/07 (Period1) and between
6/1/07 and 5/31/08 (Period 2), total of 3041 and 3351 cases were
performed respectively. In Period 1 only venous cases could be done in the
office. Prior to arteriogram BUN and Creatinine level is obtained. The
number of percutaneous cases done in hospital and office setting were
analyzed and revenue was calculated based on the 2008 Medicare fee
schedule for our region. Thirty day amputation rate and mortality was
documented. Hospital DRG payment schedule was obtained.
Results: In Period 1, 670 (22% of total) percutaneous procedures were
performed as compared to 1502 (44.8%) in Period 2, a two fold increase. In
Period1, 1.5% of total cases were done in office as compared to 31% in Period
2. There was a fivefold increase in revenue from these procedures. There was
no mortality or amputation as a result of procedures performed in office.
There was no anesthesiologist’s expense and minimal pre-procedure ex-
pense. Total payment byMedicare, DRG payment to hospital plus physician
component is higher in all the cases.
Procedure
Period1 Period1 Period2 Period2 R/C R/C Hosp.
Hospital Office Hospital Office Hospital Office DRG
Cath Ins. 198 240 146 $ 309 $ 947 $ 1581
Cath Rem 62 38 122 $ 134 $ 160 $ 361
Fist Thro 71 29 113 $ 426 $2,232 $2,655
Fist Angio 94 28 238 $ 460 $2,450 $2,977
Fist Stent 1 5 9 $ 605 $4,900 $5,808
Fist coil 22 $1,170 $2,407 $5,741
Fist 8 11 47 $ 183 $ 633 $ 613
Aor Angio 16 48 33 $ 589 $3,854 $2,977
Aor Run 114 47 104 $ 267 $1,397 $1,895
Aor Stent 7 18 11 $ 719 $5,860 $5,808
Aorta 18 12 $ 204 $1,003 $1,895
EVLT 38 40 132 $ 324 $1,539 $1,695
Micro 13 4 19 $ 423 $ 423 $1,695
Venogram 4 4 8 $ 208 $1,079 $1,895
Total 626 44 486 1016
Key: Cath-Catheter, Ins-Insert, Fist-Fistulogram, Thro-Thrombectomy,
Angio-Angioplasty, Aor-Aortogram, Run-runoff, EVLT-Endovenous laser
Therapy, Micro-Microphlebectomy, R/C-Revenue per case.
Conclusions: AVascular Surgery practice can benefit from office based
procedures. Procedures can be done safely. It results in an increase in
number of percutaneous procedures and revenue. There are significant
savings to health care system. Surgeons can control their schedule. Every
vascular surgeon should consider doing these procedures in office.Author Disclosures: K. Jain, None; J.S. Munn, None; M.C. Rummel,
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SS22.
Totally Laparoscopic Aortic Surgery: Experience In A French Academic
Center
Jérôme Cau, Jean-Baptiste Ricco. Poitiers University Hospital, Poitiers,
France
Background: The application of laparoscopic techniques for vascular
procedures has been limited by factors such as difficulties in aortic exposure
and anastomosis techniques, as well as the concurrent competitive progress
of endovascular surgery. The purpose of this study was to review the
outcomes for laparoscopic aortic interventions in the endovascular era.
Methods: Retrospective analysis was carried out for a series of 219
patients who underwent a totally laparoscopic aortic procedure for treat-
ment of aortic occlusive disease (AOD; n 127) or abdominal aortic
aneurysm (AAA; n80) and 12 aorto-renal bypass. This series did not
include patients operated in others centers (110 aortic bypasses).
Findings: Mean patient age was 61 years and the sex ratio was 3 men
for 1 woman. The mean operative time of procedures for AOD was 223
/ 50 minutes, with a mean clamp time of 56 / 21 minutes. 3.6% of
the AOD procedures had to be converted to open. For laparoscopic AAA
procedures, the mean operative time was 262 / 57 minutes and the
mean clamp time was 103 / 15 minutes. 8 conversions (10%) to open
procedure had to be performed in this subgroup. The 30-day mortality rate
was 0.9%. Overall mortality rate was 13.4% during a mean follow-up time of
16.2 months. The primary patency rate was 100%.
Conclusions:Totally laparoscopic aortic surgery is feasible and showed
promising and satisfactory results in our experience. Precise indications for
this kind of surgery, compared to endovascular and open surgery, remain to
be determined by randomized studies. Nevertheless, it is a difficult tech-
nique. Further development will rely on effective training, advances in
technique and instrumentation.
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The Incidence of Infectious Complications After Elective Vascular
Surgery in the United States
Todd R Vogel, Viktor Y Dombrovskiy, Jeffrey L Carson, Paul B Haser,
Stephen F Lowry, Alan M Graham. UMDNJ-Robert Wood Johnson Med-
ical School, New Brunswick, NJ
Objective: To evaluate the incidence and socio-demographics of post-
operative infectious complications after elective vascular surgery, to define
vascular procedures with the greatest risk of developing nosocomial infec-
tions, and to assess the impact of infection on utilization.
Methods:TheNationwide Inpatient Sample (2002-2006) was utilized
to identify major vascular procedures by ICD-9-CM codes. Infectious
complications including pneumonia (PNA), urinary tract infections (UTI),
postoperative sepsis, and surgical site infections (SSI) were identified. Case
mix-adjusted rates for age, race, gender, and comorbidities were calculated
using a multivariate logistic regression model with infectious complications
as an outcome.
